SCHEMBL528282

SCHEMBL528282

COc1cc(OC)cc(C(C)OC(N)=O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.43
ALDH1A1 P00352 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
TNF P01375 1/20 0.40
ALOX5 P09917 2/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
TDP1 Q9NUW8 1/20 0.37
PARP1 P09874 2/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
PARP10 Q53GL7 1/20 0.37
PARP2 Q9UGN5 1/20 0.37
PARP4 Q9UKK3 1/20 0.37
PTGS2 P35354 3/20 0.37
PTGS1 P23219 2/20 0.37
AKR1C3 P42330 2/20 0.37
AKR1C2 P52895 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27643039 0.83 KMT2A (0.44) KMT2AALDH1A1L3MBTL1TDP1PTGS2
SCHEMBL28804124 0.83 L3MBTL1 (0.57) KMT2AALDH1A1L3MBTL1TDP1PARP1
SCHEMBL28804126 0.83 L3MBTL1 (0.57) KMT2AALDH1A1L3MBTL1TDP1PARP1
SCHEMBL28415694 0.81 ALOX5 (0.51) KMT2AL3MBTL1ALOX5TDP1PARP1
SCHEMBL12327035 0.78 ALOX5 (0.61) L3MBTL1ALOX5TDP1PTGS2PTGS1
SCHEMBL1130219 0.77 L3MBTL1 (0.41) KMT2AL3MBTL1TNFPDE4APDE4B
SCHEMBL28690146 0.76 CES2 (0.40) TSHR
SCHEMBL28690149 0.76 CES2 (0.40) TSHR
SCHEMBL20362018 0.75 ADRB1 (0.43) KMT2AL3MBTL1TNF
1,3,5-Trimethoxybenzene SCHEMBL28245468 0.75 ALDH1A1 (0.65) KMT2AALDH1A1PDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022178428-A9 TARGETED BIFUNCTIONAL DEGRADERS AND METHODS USING SAME YALE UNIVERSITY (US) 2023-08-17 WO disclosed
EP-2598170-A2 DRUG-LIGAND CONJUGATES, SYNTHESIS THEREOF, AND INTERMEDIATES THERETO Smartcells, Inc. (US) 2013-06-05 EP disclosed
WO-2012015681-A2 DRUG-LIGAND CONJUGATES, SYNTHESIS THEREOF, AND INTERMEDIATES THERETO SMARTCELLS, INC. (US) 2012-02-02 WO disclosed